Clinical Trial Update: Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer [NA]

View source ↗

Summary

Phase II neoadjuvant chemotherapy trial in locally advanced breast cancer evaluating doxorubicin followed by docetaxel-cisplatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Platinol (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Breast Cancer | NA | Status: COMPLETED